eCTD Press Release from Diamond BioPharm
- Details
- Category: Press Releases
- Published on Thursday, 04 February 2010 16:31
- Hits: 3078
Important facts:
eCTD Gene Therapy Product Submission from UK company
- DOSSIER - 3 years in the making, researching the development and regulatory requirements for an advanced therapy, writing complex modules.
- CO-OPERATION - more than 3 years working closely with the overseas client - no or new guidelines to work around for an advanced therapy
- ADAPTING - as the Regulatory guidelines progressed
- WORKING - hand in hand with the scientists
- LIAISING - with Regulators in an ever advancing field
- PROVIDING - strategic advice and leadership throughout serving as the Regulatory function.
- eCTD - 6 months to find the right format, installation, I Q,OQ,PQ validation.
- Using structured template to create the perfect format
- Instructing/training on dossier format.
- Ensuring consistency of documentation
- Collating modules for input and hyper-linking
- Complex tracking system to ensure every document uploaded
- Full quality control assurance
- Successful pilot test with the Regulatory Authority
- Deadline 24th December and we did it with 24 hours to spare

Notes to editors
Diamond Pharma Services is a group of companies which provides out-sourced support solutions in Europe for pharmaceutical companies and which comprises Diamond BioPharm Limited (Regulatory), Diamond PV Services Limited (Pharmacovigilance & Medical Information), Diamond Compliance Limited (Quality), Diamond Clear PILs Limited (PIL User Testing) and Diamond IT Services Limited (Technical Support). The founder of Diamond Pharma Services, Maureen Graham, founded the first Diamond company –Diamond BioPharm Limited – in 2005. Diamond Pharma Services is a privately owned organisation.
Website: www.diamondpharmaservices.com
For further information please contact: David Page, Mulberry Advertising
This email address is being protected from spambots. You need JavaScript enabled to view it.

